Table 1.
Pathways | HRS Silencing * |
P31–43 * and ** | Loxorubine * | ATIs | Poly I:C *** |
---|---|---|---|---|---|
Delay of vesicular
trafficking (EEA1, LAMP2, EGFR) |
YES | YES | YES | Not tested | Not tested |
Activation of innate
immunity (IL15, IL15Ralpha) |
YES | YES | YES | Yes | YES |
Activation of inflammatory markers (NFkB and MAPK) | YES | YES | YES | Yes | YES |
TLRs
activation (MXA, Mydd 88, INF-alpha) |
YES | YES | YES | Yes | YES |